ES2180995T3 - Nuevos derivados de tiazolidina-2,4-diona substituidos, sus procedimientos de obtencion y las composiciones farmaceuticas que los contienen. - Google Patents
Nuevos derivados de tiazolidina-2,4-diona substituidos, sus procedimientos de obtencion y las composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2180995T3 ES2180995T3 ES97925034T ES97925034T ES2180995T3 ES 2180995 T3 ES2180995 T3 ES 2180995T3 ES 97925034 T ES97925034 T ES 97925034T ES 97925034 T ES97925034 T ES 97925034T ES 2180995 T3 ES2180995 T3 ES 2180995T3
- Authority
- ES
- Spain
- Prior art keywords
- invention refers
- general formula
- present
- dion
- thiazolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical group O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical compound C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 229940125708 antidiabetic agent Drugs 0.000 abstract 1
- GEAXLHPORCRESC-UHFFFAOYSA-N chlorocyclohexatriene Chemical class ClC1=CC=C=C[CH]1 GEAXLHPORCRESC-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE AL CAMPO DE LA QUIMICA Y EN PARTICULAR AL DE LA QUIMICA TERAPEUTICA. LA PRESENTE INVENCION SE REFIERE MAS CONCRETAMENTE A NUEVAS 5 - FENOXIALQUIL 2,4 TIAZOLIDINEDIONAS DE FORMULA GENERAL (I) EN LAS QUE A REPRESENTA UN GRUPO ALQUILENO LINEAL O RAMIFICADO QUE COMPRENDE ENTRE 2 Y 16 ATOMOS DE CARBONO; D REPRESENTA UNA ESTRUCTURA AROMATICA MONO-, BI- O TRICICLICA, HOMO- O HETEROCARBONADA QUE PUEDEN INCLUIR UNO O VARIOS HETEROATOMOS; X REPRESENTA EL SUBSTITUYENTE DE LA ESTRUCTURA AROMATICA Y ES TAL COMO SE DEFINE EN LA REIVINDICACION 1; N ES UN NUMERO ENTERO DE ENTRE 1 Y 3; CON LA RESTRICCION DE QUE SI A REPRESENTA UN RADICAL BUTILO, (A) NO REPRESENTA EL GRUPO 4 - CLOROFENILO. LA INVENCION SE REFIERE TAMBIEN A LAS FORMAS TAUTOMERAS, A LOS ENANTIOMEROS, LOS DIASTEREOISOMEROS Y EPIMEROS DE LOS COMPUESTOS DE FORMULA GENERAL (I), EN FORMA LIBRE O SALIFICADA. LA PRESENTE INVENCION SE REFIERE ADEMAS A PROCEDIMIENTO DE OBTENCION DE LOS COMPUESTOS DE FORMULA GENERAL (I),A SU UTILIZACION COMO AGENTES ANTIDIABETICOS, Y EN EL TRATAMIENTO DEL SINDROME METABOLICO DE LA INSULINORRESISTENCIA, ASI COMO A LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS DE FORMULA GENERAL (I).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9607070A FR2749583B1 (fr) | 1996-06-07 | 1996-06-07 | Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2180995T3 true ES2180995T3 (es) | 2003-02-16 |
Family
ID=9492815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97925034T Expired - Lifetime ES2180995T3 (es) | 1996-06-07 | 1997-06-02 | Nuevos derivados de tiazolidina-2,4-diona substituidos, sus procedimientos de obtencion y las composiciones farmaceuticas que los contienen. |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US6437143B2 (es) |
| EP (1) | EP0918759B1 (es) |
| JP (2) | JP3067809B2 (es) |
| KR (1) | KR20000016412A (es) |
| CN (2) | CN1075811C (es) |
| AR (1) | AR008387A1 (es) |
| AT (1) | ATE222897T1 (es) |
| AU (1) | AU726549B2 (es) |
| BR (1) | BR9709654A (es) |
| CA (1) | CA2257275A1 (es) |
| CZ (1) | CZ397598A3 (es) |
| DE (1) | DE69715009T2 (es) |
| DK (1) | DK0918759T3 (es) |
| EE (1) | EE04015B1 (es) |
| ES (1) | ES2180995T3 (es) |
| FR (1) | FR2749583B1 (es) |
| HU (1) | HUP0001744A3 (es) |
| ID (1) | ID17810A (es) |
| IL (1) | IL127408A (es) |
| NO (1) | NO312100B1 (es) |
| NZ (1) | NZ333645A (es) |
| PL (1) | PL330363A1 (es) |
| PT (1) | PT918759E (es) |
| RU (1) | RU2169144C2 (es) |
| SK (1) | SK164598A3 (es) |
| TR (1) | TR199802518T2 (es) |
| TW (1) | TW400330B (es) |
| UA (1) | UA57024C2 (es) |
| WO (1) | WO1997047612A1 (es) |
| ZA (1) | ZA974984B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083966A (en) * | 1998-08-31 | 2000-07-04 | University Of Florida | Thiazoline acid derivatives |
| CN1585639A (zh) * | 1998-09-21 | 2005-02-23 | 佛罗里达大学研究基金会 | 抗疟疾制剂 |
| KR20010112328A (ko) * | 1999-03-18 | 2001-12-20 | 우에노 도시오 | 티아졸리딘 유도체의 제조 방법 |
| DE60005973T2 (de) | 1999-08-27 | 2004-05-13 | Eli Lilly And Co., Indianapolis | Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren |
| FR2812547B1 (fr) * | 2000-08-04 | 2002-10-31 | Lipha | Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
| FR2822069B1 (fr) * | 2001-03-19 | 2003-06-20 | Lipha | Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete |
| FR2826278B1 (fr) * | 2001-06-20 | 2005-03-25 | Lipha | Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant |
| CN100516020C (zh) * | 2001-09-26 | 2009-07-22 | 艾米斯菲尔技术有限公司 | 通过二羧化物中间体制备苯氧基链烷酸、链烯酸和炔酸及其盐的方法 |
| FR2838968A1 (fr) * | 2002-04-30 | 2003-10-31 | Lipha | Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete |
| SE0201937D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
| FR2845003A1 (fr) * | 2002-09-30 | 2004-04-02 | Merck Sante Sas | Utilisation de derives de thiazolidinedione comme inhibiteurs de l'aldose reductase |
| WO2005034949A1 (en) * | 2003-09-09 | 2005-04-21 | University Of Florida | Desferrithiocin derivatives and their use as iron chelators |
| US20060263453A1 (en) * | 2004-11-01 | 2006-11-23 | Thomas Smith | Methods and compositions for modulating glutamate dehydrogenase |
| TR201910900T4 (tr) | 2005-04-04 | 2019-08-21 | Univ Florida | Desferritiyokin polieter analogları. |
| WO2008115433A1 (en) * | 2007-03-15 | 2008-09-25 | University Of Florida | Desferrithiocin polyether analogues |
| EP3788877B1 (en) * | 2007-04-11 | 2024-08-07 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| DE102007028925A1 (de) * | 2007-06-22 | 2008-12-24 | Saltigo Gmbh | Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden |
| EP3620161A1 (en) | 2011-12-16 | 2020-03-11 | University of Florida Research Foundation, Inc. | Uses of 4'-desferrithiocin analogs |
| US9815777B2 (en) | 2013-09-22 | 2017-11-14 | Jiva Pharma, Inc. | Metformin salts to treat Type2 diabetes |
| AU2014352780A1 (en) | 2013-11-22 | 2016-06-09 | University Of Florida Research Foundation, Inc. | Desferrithiocin analogs and uses thereof |
| KR20170140306A (ko) | 2015-04-27 | 2017-12-20 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 대사적으로 프로그램화된 금속 킬레이트화제 및 그의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| SU1611216A3 (ru) * | 1986-12-29 | 1990-11-30 | Пфайзер Инк (Фирма) | Способ получени производных тиазолидиндиона или их фармацевтически приемлемых солей с щелочными металлами |
| TW268952B (es) * | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
| US5614544A (en) * | 1993-09-14 | 1997-03-25 | Takeda Chemical Industries, Ltd. | Oxazolidinedione derivatives and their use |
| US5965589A (en) * | 1994-08-10 | 1999-10-12 | Takeda Chemical Industries, Ltd. | Thiazolidinedione derivatives, their production and use |
-
1996
- 1996-06-07 FR FR9607070A patent/FR2749583B1/fr not_active Expired - Fee Related
-
1997
- 1997-02-06 UA UA99010018A patent/UA57024C2/uk unknown
- 1997-06-02 WO PCT/EP1997/002851 patent/WO1997047612A1/fr not_active Ceased
- 1997-06-02 AU AU30317/97A patent/AU726549B2/en not_active Ceased
- 1997-06-02 US US09/202,076 patent/US6437143B2/en not_active Expired - Fee Related
- 1997-06-02 IL IL12740897A patent/IL127408A/en not_active IP Right Cessation
- 1997-06-02 JP JP10501140A patent/JP3067809B2/ja not_active Expired - Fee Related
- 1997-06-02 AT AT97925034T patent/ATE222897T1/de not_active IP Right Cessation
- 1997-06-02 DK DK97925034T patent/DK0918759T3/da active
- 1997-06-02 DE DE69715009T patent/DE69715009T2/de not_active Expired - Fee Related
- 1997-06-02 PT PT97925034T patent/PT918759E/pt unknown
- 1997-06-02 RU RU99100100/04A patent/RU2169144C2/ru not_active IP Right Cessation
- 1997-06-02 CN CN97195320A patent/CN1075811C/zh not_active Expired - Fee Related
- 1997-06-02 SK SK1645-98A patent/SK164598A3/sk unknown
- 1997-06-02 BR BR9709654A patent/BR9709654A/pt not_active IP Right Cessation
- 1997-06-02 CZ CZ983975A patent/CZ397598A3/cs unknown
- 1997-06-02 NZ NZ333645A patent/NZ333645A/xx unknown
- 1997-06-02 PL PL97330363A patent/PL330363A1/xx unknown
- 1997-06-02 EE EE9800426A patent/EE04015B1/xx not_active IP Right Cessation
- 1997-06-02 ES ES97925034T patent/ES2180995T3/es not_active Expired - Lifetime
- 1997-06-02 EP EP97925034A patent/EP0918759B1/fr not_active Expired - Lifetime
- 1997-06-02 HU HU0001744A patent/HUP0001744A3/hu unknown
- 1997-06-02 TR TR1998/02518T patent/TR199802518T2/xx unknown
- 1997-06-02 KR KR1019980709995A patent/KR20000016412A/ko not_active Ceased
- 1997-06-02 CA CA002257275A patent/CA2257275A1/en not_active Abandoned
- 1997-06-05 ZA ZA9704984A patent/ZA974984B/xx unknown
- 1997-06-06 AR ARP970102468A patent/AR008387A1/es not_active Application Discontinuation
- 1997-06-06 TW TW086107848A patent/TW400330B/zh active
- 1997-06-09 ID IDP971967A patent/ID17810A/id unknown
-
1998
- 1998-12-04 NO NO19985671A patent/NO312100B1/no not_active IP Right Cessation
-
1999
- 1999-12-15 JP JP11355996A patent/JP2000226379A/ja active Pending
-
2001
- 2001-01-22 CN CN01103050A patent/CN1341588A/zh active Pending
-
2002
- 2002-06-27 US US10/180,071 patent/US20030100587A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2180995T3 (es) | Nuevos derivados de tiazolidina-2,4-diona substituidos, sus procedimientos de obtencion y las composiciones farmaceuticas que los contienen. | |
| AR047823A1 (es) | Derivados de 1,2,3,4-tetrahidroisoquinolina sustituida | |
| AR048282A1 (es) | Indol- o - glucosidos sustituidos | |
| ES2107698T3 (es) | Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento, como inhibidores del intercambio celular de na+/h+ o como agente de diagnostico, asi como medicamento que las contiene. | |
| AR034282A1 (es) | Derivados de difenilazetidinona, medicamentos que contienen estos compuestos, procedimiento para su preparacion, y su utilizacion para la preparacion de medicamentos | |
| AR045901A1 (es) | Glucocorticoesteroides especificos con actividades antiinflamatoria y antialergica,composiciones farmaceuticas que los contienen,y procedimientos para su preparacion, | |
| AR008377A1 (es) | Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto | |
| DE60307179D1 (de) | Vor UV-Strahlen schützende Zusammensetzungen | |
| AR037534A1 (es) | Derivado de adamantano, su uso en la fabricacion de un medicamento para usar en terapia, composicion farmaceutica, proceso para la preparacion de dicho compuesto y dicha composicion y compuestos intermediarios | |
| ES2123039T3 (es) | Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| AR028624A1 (es) | Heterociclilalquilaminas como antagonistas de receptores muscarinicos | |
| BR9508608A (pt) | Composto formulação farmacêutica e processo para prevenir ou tratar arritmia | |
| AR007079A1 (es) | Derivados de alquilaminobenzotiazol y benzoxazol , un proceso para su preparación, una composición farmacéutica que los contiene, y un proceso para preparar dicha composición | |
| ES2149777T3 (es) | Derivados de triazol que tienen actividad antifungica. | |
| HUP0103203A2 (hu) | Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| NO932992L (no) | Nye polyjoderte forbindelser, fremgangsmaate for deres fremstilling og kontrastmidler inneholdende dem | |
| FI803264L (fi) | 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel | |
| ES2188743T3 (es) | Compuestos de acido pirrolidinilhidroxamico y procedimiento de produccion de los mismos. | |
| ES2153019T3 (es) | Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| CO5590858A2 (es) | Composicion fungicida basada en un derivado de piridilmetilbenzamida e iprovalicarb | |
| AR050260A1 (es) | Derivados de diarilmetilpiperazinas, su preparacion y su utilizacion | |
| ES2125963T3 (es) | Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen. | |
| AR046768A1 (es) | Derivados de piridin-tetrazol, metodos de obtencion y composiciones farmaceuticas | |
| ES8401964A1 (es) | Un procedimiento para la preparacion de un derivado de piridoindol. | |
| DK524283D0 (da) | Fremgangsmade til fremstilling af nitrosoureaderivater |